• Head & Senior Scientist, Clinical & Molecular Epidemiology of Cancer Unit, Hospital del Mar Institute of Medical Research (IMIM)
• Professor of Preventive Medicine & Public Health, School of Medicine, Universitat Autonoma de Barcelona (UAB)
• Adjunct Professor of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill (UNC)
After graduating from the UAB School of Medicine, Dr. Porta was during 3 years a Fellow with the Division of Clinical Pharmacology of UAB. He was then awarded a Fulbright scholarship to pursue the Master of Public Health (MPH) program at UNC, where he subsequently was a Visiting Instructor and Burroughs Wellcome Postdoctoral Fellow in Pharmacoepidemiology, a subject whose graduate teaching he contributed to pioneer in the United States and to expand internationally.
The Unit of Dr. Porta at IMIM has a distinguished record of internationally-recognized research on the clinical and molecular epidemiology of pancreatic cancer, with a focus on the role of gene-environment interactions –including Persistent Organic Pollutants (POPs)– in the etiopathogenesis of pancreatic diseases. He has also published extensively on human biomonitoring and the uses of biomarkers to assess the impact of POPs on human health.
In addition to UNC and the UAB School of Medicine, Dr. Porta has also taught graduate courses and seminars on clinical, molecular, and environmental epidemiology at several other American and world institutions, including McGill University (Montreal, Canada), Imperial College (London), several universities in Kuwait, Brazil and Mexico, and at Harvard, where he was on sabbatical in 1998 & 1999. He has acted as an external grant and doctoral thesis reviewer for the Karolinska Institutet, the Finnish Academy, Diabetes UK, the Environment and Health Fund - Israel, and several other European and American scientific organizations.
He is (co)author of over 350 papers, published in journals as The Lancet, PLoS Medicine, PLoS One, Endocrine Reviews, Journal of Clinical Oncology, Gut, International Journal of Cancer, British Journal of Cancer, Mutation Research, Carcinogenesis, Molecular Carcinogenesis, Cancer Causes & Control, Occupational & Environmental Medicine, Journal of Epidemiology & Community Health, Environmental Health Perspectives, Mutagenesis, Environmental & Molecular Mutagenesis, Proteomics - Clinical Applications, Clinical Chemistry, Chemosphere, Environmental Research, Environmental Science & Technology, Environment International, Milbank Quarterly, Epidemiology, Journal of Clinical Epidemiology, International Journal of Epidemiology, Diabetes Care, Diabetologia or Preventive Medicine, among others.
He has been President of the Spanish Society of Epidemiology (SEE), as well as European Councillor of the International Epidemiological Association (IEA) and Chairman of the IEA European Epidemiology Federation.
Appointed as Editor by the IEA, in 2008 and 2014 Dr. Porta published the 5th. and 6th. editions of 'A dictionary of epidemiology' (New York, Oxford University Press; 6th. edition: 2014: http://www.amazon.com/Miquel-Porta/e/B00IZJZW3S/ref=dp_byline_cont_pop_book_1 ).
Beyond his main lines of research, Dr. Porta has written on topics such as causality, persistent organic pollutants and public health, genome metaphors, the bibliographic impact factor of scientific journals, or the societal roles of scientific associations. He thinks that scholars have a certain responsibility to transfer knowledge to society; thus, he regularly collaborates with a variety of governmental and non-governmental organisations, and companies, and writes for journals as El País and other media.
Dr Porta is an active member of the editorial boards of the ‘Journal of Clinical Epidemiology’ and ‘Preventive Medicine’, an editorial consultant to ‘The Lancet’, a Co-editor of the ‘European Journal of Clinical Investigation’ and of the ‘European Journal of Epidemiology’, a Deputy Editor of the ‘Journal of Epidemiology & Community Health’, and a ‘Faculty Member’ of ‘Faculty of 1000 Medicine’. He speaks, reads and writes fluently in Catalan, Spanish, French and English.